What is the recommended dosing of fluvoxamine for the treatment of obsessive‑compulsive disorder in adults and adolescents?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Fluvoxamine Dosing for OCD

For adults with OCD, start fluvoxamine at 50 mg once daily at bedtime, then increase by 50 mg every 4-7 days as tolerated to a target range of 100-300 mg/day, with doses above 100 mg split into two divided doses (larger dose at bedtime). 1

Adult Dosing Algorithm

Initial Phase:

  • Start: 50 mg once daily at bedtime 1
  • Titration: Increase by 50 mg increments every 4-7 days based on tolerability 1
  • Target range: 100-300 mg/day (established in controlled trials) 1

Dosing Schedule:

  • ≤100 mg/day: Single daily dose at bedtime 1
  • 100 mg/day: Split into two divided doses, with the larger dose at bedtime 1

  • Maximum: 300 mg/day 1

Treatment Duration:

  • Allow 8-12 weeks at therapeutic dose to assess efficacy 2
  • Note: Significant improvement may be observed within 2 weeks, with greatest gains occurring early in treatment 2, 3

Pediatric Dosing (Ages 8-17)

For children and adolescents, start at 25 mg once daily at bedtime, increase by 25 mg every 4-7 days, with maximum doses of 200 mg/day for children ≤11 years (especially females who require lower doses) and up to 300 mg/day for adolescents. 1

Age-Specific Considerations:

  • Children (8-11 years):

    • Start: 25 mg once daily at bedtime 1
    • Titration: 25 mg increments every 4-7 days 1
    • Maximum: 200 mg/day 1
    • Critical caveat: Female children have 1.5-2.7 fold higher drug exposure than males and may achieve therapeutic benefit at lower doses 1, 4
  • Adolescents (12-17 years):

    • Start: 25 mg once daily at bedtime 1
    • Titration: 25 mg increments every 4-7 days 1
    • Maximum: 300 mg/day (same as adults) 1
    • Pharmacokinetics similar to adults at 300 mg/day 1

Dosing Schedule for Pediatrics:

  • ≤50 mg/day: Single daily dose at bedtime 1
  • 50 mg/day: Split into two divided doses, larger dose at bedtime 1

Special Populations

Elderly or Hepatically Impaired:

  • Use slower titration due to 50% reduced clearance and 40% higher peak concentrations 1
  • Start at lower doses and increase more gradually 1

Key Clinical Considerations

Efficacy Expectations:

  • Response rate (≥25% symptom reduction): 38-52% with fluvoxamine vs 0-18% with placebo 5
  • Mean Y-BOCS reduction: 4-5 units vs 2 units with placebo 1
  • Early response at week 2 predicts sustained benefit 3

Common Pitfalls:

  • Underdosing: OCD requires higher SSRI doses than depression or other anxiety disorders 2
  • Inadequate trial duration: Must allow full 8-12 weeks at therapeutic dose before declaring treatment failure 2
  • Ignoring gender differences in children: Female children have significantly higher drug exposure and may need lower doses 1, 4
  • Single daily dosing at high doses: Doses >100 mg (adults) or >50 mg (pediatrics) should be split to improve tolerability 1

Tolerability:

  • Most common adverse events: nausea (>10%), somnolence, asthenia, headache 5
  • Higher doses associated with greater efficacy but also higher dropout rates 2
  • Generally better tolerated than clomipramine with similar efficacy 2, 5

Maintenance:

  • Continue treatment long-term for this chronic condition 1
  • Periodically reassess and maintain lowest effective dose 1
  • Taper gradually if discontinuing to avoid withdrawal symptoms 1

Related Questions

What are the recommended fluvoxamine dosage guidelines for adults with obsessive‑compulsive disorder, children and adolescents, and patients with liver disease or the elderly?
In a 20‑year‑old male with stable obsessive‑compulsive disorder on fluvoxamine 150 mg daily and aripiprazole (Abilify) 10 mg daily, how should excessive daytime sleepiness and difficulty getting out of bed be managed?
In a 16-year-old female who developed excessive drowsiness after increasing Luvox (fluvoxamine) from 50 mg to 75 mg, how should the sedation be managed?
What is the best medication for Obsessive-Compulsive Disorder (OCD) with minimal sexual side effects?
What is the recommended starting dose, titration schedule, maximum dose, and safety precautions for fluvoxamine in an adult with major depressive disorder, obsessive‑compulsive disorder, or anxiety?
What is Zocor (simvastatin)?
Is it safe to apply over‑the‑counter heat patches to the facial skin?
What is the appropriate management for a patient with atrial fibrillation of 4‑day duration who is taking apixaban (Eliquis) and perindopril?
Should a patient with nonobstructive coronary artery disease continue both aspirin and clopidogrel (Plavix) if he has no bleeding problems?
Is a male-to-female transgender patient who has completed five facial laser hair‑removal sessions, still has residual terminal facial hair, and experiences dysphoric symptoms several times per day but does not meet criteria for full body‑dysmorphic disorder eligible for electrolysis authorization (RFS) given the two required criteria?
What are the brand names of naloxone?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.